Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Radiation Injuries 1 Prostate Adenocarcinoma 1 Lymphatic Metastasis 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Breast Neoplasms 1

Interventions

Oxaliplatin 42 Fluorouracil 27 Capecitabine 24 pembrolizumab 21 S 1 (combination) 19 Paclitaxel 19 Leucovorin 16 Nivolumab 13 sintilimab 12 Drug Therapy 12 Docetaxel 12 tislelizumab 11 Trastuzumab 10 Cisplatin 10 Irinotecan 8 Bevacizumab 8 trastuzumab deruxtecan 7 spartalizumab 7 fludarabine 7 XELOX 7 Surgical Procedures, Operative 7 Radiotherapy 7 Cyclophosphamide 7 Biopsy 7 disitamab vedotin 6 Hyperthermic Intraperitoneal Chemotherapy 6 lenvatinib 5 apatinib 5 Specimen Handling 5 Ramucirumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Stomach Neoplasms × Lymph Node Excision × Clear all

NCT06161207 2024-06-24

3D-4K-ICG

Fujian Medical University

Phase 3 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡